Hospital-based addiction consult services show promise in improving opioid use disorder treatment uptake

FHS
July 30, 2024
3:16 am

Previous research has found that over 80 percent of people with opioid use disorder (OUD) do not receive evidence-based lifesaving medications.

Updated: J&J to buy Intra-Cellular for $14.6B in latest neuroscience bet

Johnson & Johnson is acquiring Intra-Cellular Therapies for $14.6 billion in the biggest biotech M&A transaction since 2023. The deal signals growing excitement in neuroscience

January 14, 2025

PTC Therapeutics Inc Patent Filing for Huntington’s Disease Treatment

Share this article According to GlobalData’s company profile on PTC Therapeutics, Human telomerase RT biomarker was a key innovation area identified from patents. PTC Therapeutics‘s

March 29, 2024

New study links persistent SARS-CoV-2 proteins to long COVID symptoms

Brigham researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.